ACELYRIN

About:

ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.

Website: https://acelyrin.com/

Twitter/X: acelyrin

Top Investors: OrbiMed, RTW Investments, Samsara BioCapital, Marshall Wace, Surveyor Capital

Description:

ACELYRIN is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of promising drug candidates and by leveraging its expertise to rapidly advance these medicines to patients.

Total Funding Amount:

$558M

Headquarters Location:

Los Angeles, California, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)acelyrin.com

Founders:

Robert Carey, Shao-Lee Lin

Number of Employees:

101-250

Last Funding Date:

2022-09-13

IPO Status:

Public

© 2025 bioDAO.ai